NewswireToday - /newswire/ -
Winston-Salem, NC, United States, 2012/05/16 - SmallCapReview.com, A leading site for news and information on small caps, penny stocks and microcaps is adding OraSure Technologies (Nasdaq: OSUR) and Velti (Nasdaq: VELT)to its list of stocks "On the Radar".
OraSure (OSUR) is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions.
Its innovative products include rapid tests for the detection of antibodies to HIV and HCV at the point of care and testing solutions for detecting various drugs of abuse. In addition, the Company is a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities.
The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health.
OSUR Investor Highlights
Announced that the U.S. Food and Drug Administration (FDA) Blood Products Advisory Committee provided a unanimous positive recommendation for the Company's OraQuick® In-Home HIV Test.
Consolidated revenues were $20.9 million for the first quarter of 2012, a 20% increase from the comparable quarter of 2011.
Cash totaled $22.8 million at March 31, 2012.
According to the Centers for Disease Control and Prevention, despite current testing options, there are approximately 1.2 million people in the U.S. that have HIV and approximately 240,000 of them are unaware of their status.
The OraQuick ADVANCE® test is the first and only FDA-approved and CLIA-waived rapid point-of-care test that can detect antibodies to both HIV-1 and HIV-2 in oral fluid in 20 minutes.
Velti (VELT) is a leading global provider of mobile marketing and advertising technology and solutions that enable brands, advertising agencies, mobile operators and media to implement highly targeted, interactive and measurable campaigns by communicating with and engaging consumers via their mobile devices.
The Velti platform, called Velti mGage™, allows customers to use mobile and traditional media to reach targeted consumers, engage the consumer through the mobile Internet and applications, convert them into customers and continue to actively manage the relationship through the mobile channel.
VELT Investor Highlights
Announced first quarter revenue of $51.8 million, growth of 75%, compared to Q1 2011.
Announced first quarter adjusted EBITDA of $4.6 million, growth of 260%, compared to Q1 2011.
Increases annual revenue and adjusted EBITDA guidance and reiterates commitment to achieve break-even operating cash flow by Q3 2012 and positive free cash flow by Q4 2012.
Velti and Ford Motor Company announced that their joint December 2011 campaign was named the 2012 Mobile Merit Award winner for the Best Brand or Agency in Mobile Marketing.
Announced the Open Device Identification Number Working Group, a consortium focused on developing an alternative secure anonymous device identifier for the mobile advertising industry.
To learn more about OSUR and VELT visit SmallCapReview.com/.
Features available at SmallCapReview.com include in-depth profiles of select Small-Cap/Penny Stocks as well as the most comprehensive and up to date news available on the small-cap market.
No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. Nothing within our site should be construed as an offer or solicitation to buy or sell products or securities. The companies we profile may lack an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. SmallCapReview.com has not been compensated by any of the above mentioned companies.
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play.